Id Pharma Co., Ltd.
Records under this name other than the patents Id Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 9 of 9 · Back to Id Pharma Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,447,432 | Method for Producing Induced Pluripotent Stem Cells Formerly held In force · High confidence | In force | High confidence | |
| US 10,704,061 | Lentiviral vectors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,220,087 | Optimized HIV Envelope Gene and Expression Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,792,357 | Optimized HIV envelope gene and expression thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,103,574 | Infectious disease vaccine using non-infectious paramyxovirus particle Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,215,334 | Polynucleotide for modifying target sequence and use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,017,784 | Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein Formerly held In force Term ended Oct 27, 2026 · From the USPTO record | In force | Term ended Oct 27, 2026 | From the USPTO record |
| US 10,828,359 | Anti-Mycobacterium Tuberculosis Vaccine Using Sendai Virus as Vector Formerly held Lapsed on the fee record Ended Nov 10, 2024 · High confidence | Lapsed on the fee record | Ended Nov 10, 2024 | High confidence |
| US 6,339,079 | Steroid sulfamates, method for the production and use thereof Lapsed on the fee record Ended Jan 15, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 15, 2014 | From the USPTO record |